249 related articles for article (PubMed ID: 33314333)
1. A reporter cell system for the triggering receptor expressed on myeloid cells 2 reveals differential effects of disease-associated variants on receptor signaling and activation by antibodies against the stalk region.
Ibach M; Mathews M; Linnartz-Gerlach B; Theil S; Kumar S; Feederle R; Brüstle O; Neumann H; Walter J
Glia; 2021 May; 69(5):1126-1139. PubMed ID: 33314333
[TBL] [Abstract][Full Text] [Related]
2. Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice.
Zhao P; Xu Y; Fan X; Li L; Li X; Arase H; Tong Q; Zhang N; An Z
MAbs; 2022; 14(1):2107971. PubMed ID: 35921534
[TBL] [Abstract][Full Text] [Related]
3. Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and γ-secretase-dependent intramembranous cleavage.
Wunderlich P; Glebov K; Kemmerling N; Tien NT; Neumann H; Walter J
J Biol Chem; 2013 Nov; 288(46):33027-36. PubMed ID: 24078628
[TBL] [Abstract][Full Text] [Related]
4. Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia.
Sessa G; Podini P; Mariani M; Meroni A; Spreafico R; Sinigaglia F; Colonna M; Panina P; Meldolesi J
Eur J Neurosci; 2004 Nov; 20(10):2617-28. PubMed ID: 15548205
[TBL] [Abstract][Full Text] [Related]
5. A split-luciferase complementation, real-time reporting assay enables monitoring of the disease-associated transmembrane protein TREM2 in live cells.
Varnum MM; Clayton KA; Yoshii-Kitahara A; Yonemoto G; Koro L; Ikezu S; Ikezu T
J Biol Chem; 2017 Jun; 292(25):10651-10663. PubMed ID: 28490631
[TBL] [Abstract][Full Text] [Related]
6. TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway.
Zheng H; Jia L; Liu CC; Rong Z; Zhong L; Yang L; Chen XF; Fryer JD; Wang X; Zhang YW; Xu H; Bu G
J Neurosci; 2017 Feb; 37(7):1772-1784. PubMed ID: 28077724
[TBL] [Abstract][Full Text] [Related]
7. Reporter cell assay for human CD33 validated by specific antibodies and human iPSC-derived microglia.
Wißfeld J; Mathews M; Mossad O; Picardi P; Cinti A; Redaelli L; Pradier L; Brüstle O; Neumann H
Sci Rep; 2021 Jun; 11(1):13462. PubMed ID: 34188106
[TBL] [Abstract][Full Text] [Related]
8. LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions.
Zhao P; Xu Y; Jiang LL; Fan X; Ku Z; Li L; Liu X; Deng M; Arase H; Zhu JJ; Huang TY; Zhao Y; Zhang C; Xu H; Tong Q; Zhang N; An Z
Mol Neurodegener; 2022 Jun; 17(1):44. PubMed ID: 35717259
[TBL] [Abstract][Full Text] [Related]
9. What happens to microglial TREM2 in Alzheimer's disease: Immunoregulatory turned into immunopathogenic?
Lue LF; Schmitz C; Walker DG
Neuroscience; 2015 Aug; 302():138-50. PubMed ID: 25281879
[TBL] [Abstract][Full Text] [Related]
10. Non-pathological roles of microglial TREM2/DAP12: TREM2/DAP12 regulates the physiological functions of microglia from development to aging.
Konishi H; Kiyama H
Neurochem Int; 2020 Dec; 141():104878. PubMed ID: 33049336
[TBL] [Abstract][Full Text] [Related]
11. Novel potent liposome agonists of triggering receptor expressed on myeloid cells 2 phenocopy antibody treatment in cells.
Boudesco C; Nonneman A; Cinti A; Picardi P; Redaelli L; Swijsen S; Roewe J; Reinhardt P; Ibach M; Walter J; Pocock JM; Ren Y; Driguez PA; Dargazanli G; Eyquem S; Proto J; Flores-Morales A; Pradier L
Glia; 2022 Dec; 70(12):2290-2308. PubMed ID: 35912412
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2).
Atagi Y; Liu CC; Painter MM; Chen XF; Verbeeck C; Zheng H; Li X; Rademakers R; Kang SS; Xu H; Younkin S; Das P; Fryer JD; Bu G
J Biol Chem; 2015 Oct; 290(43):26043-50. PubMed ID: 26374899
[TBL] [Abstract][Full Text] [Related]
13. Reduced TREM2 activation in microglia of patients with Alzheimer's disease.
Okuzono Y; Sakuma H; Miyakawa S; Ifuku M; Lee J; Das D; Banerjee A; Zhao Y; Yamamoto K; Ando T; Sato S
FEBS Open Bio; 2021 Nov; 11(11):3063-3080. PubMed ID: 34523252
[TBL] [Abstract][Full Text] [Related]
14. DAP12 Stabilizes the C-terminal Fragment of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) and Protects against LPS-induced Pro-inflammatory Response.
Zhong L; Chen XF; Zhang ZL; Wang Z; Shi XZ; Xu K; Zhang YW; Xu H; Bu G
J Biol Chem; 2015 Jun; 290(25):15866-15877. PubMed ID: 25957402
[TBL] [Abstract][Full Text] [Related]
15. TREM2/DAP12 Signal Elicits Proinflammatory Response in Microglia and Exacerbates Neuropathic Pain.
Kobayashi M; Konishi H; Sayo A; Takai T; Kiyama H
J Neurosci; 2016 Oct; 36(43):11138-11150. PubMed ID: 27798193
[TBL] [Abstract][Full Text] [Related]
16. An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function.
Schlepckow K; Kleinberger G; Fukumori A; Feederle R; Lichtenthaler SF; Steiner H; Haass C
EMBO Mol Med; 2017 Oct; 9(10):1356-1365. PubMed ID: 28855300
[TBL] [Abstract][Full Text] [Related]
17. TREM2 in CNS homeostasis and neurodegenerative disease.
Painter MM; Atagi Y; Liu CC; Rademakers R; Xu H; Fryer JD; Bu G
Mol Neurodegener; 2015 Sep; 10():43. PubMed ID: 26337043
[TBL] [Abstract][Full Text] [Related]
18. TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer's disease variant
Cheng Q; Danao J; Talreja S; Wen P; Yin J; Sun N; Li CM; Chui D; Tran D; Koirala S; Chen H; Foltz IN; Wang S; Sambashivan S
J Biol Chem; 2018 Aug; 293(32):12620-12633. PubMed ID: 29599291
[TBL] [Abstract][Full Text] [Related]
19. Triggering Receptor Expressed on Myeloid Cell 2 R47H Exacerbates Immune Response in Alzheimer's Disease Brain.
Korvatska O; Kiianitsa K; Ratushny A; Matsushita M; Beeman N; Chien WM; Satoh JI; Dorschner MO; Keene CD; Bammler TK; Bird TD; Raskind WH
Front Immunol; 2020; 11():559342. PubMed ID: 33101276
[TBL] [Abstract][Full Text] [Related]
20. Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region.
Schlepckow K; Monroe KM; Kleinberger G; Cantuti-Castelvetri L; Parhizkar S; Xia D; Willem M; Werner G; Pettkus N; Brunner B; Sülzen A; Nuscher B; Hampel H; Xiang X; Feederle R; Tahirovic S; Park JI; Prorok R; Mahon C; Liang CC; Shi J; Kim DJ; Sabelström H; Huang F; Di Paolo G; Simons M; Lewcock JW; Haass C
EMBO Mol Med; 2020 Apr; 12(4):e11227. PubMed ID: 32154671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
